Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Infections and Infectious Diseases | Family Medicine

Clostridium Difficile-Associated Diarrhea Clinical Trials


A listing of Clostridium Difficile-Associated Diarrhea medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

California

Long Beach : Novo Research, Inc.

Clostridum Difficile Associated Diarrhea

View More »

Los Angeles : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Colorado

Aurora : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

District of Columbia

Washington : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Illinois

Chicago : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Indiana

Indianapolis : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Kansas

Wichita : Via Christi Research

MODIFY II: A Study of MK-6072 and MK-3415A in Antibiotic Therapy for Clostridium difficile

Wichita : Via Christi Research

Safety, Tolerance & Immunogenic Response to Vaccine for MCV4, TDaP & Bivalent rLP2086 in Children 10-12

Kentucky

Louisville : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Maryland

Baltimore : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

New Jersey

Morristown : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

New York

New Hyde Park : Parker Jewish Institute

C. diff

View More »

Stony Brook : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

North Dakota

Bismarck : St. Alexius Medical Center

A study of an investigational medication for treatment for patients with CDAD (Clostridium difficile Associated Diarrhea).

Ohio

Cleveland : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Pennsylvania

West Reading : The Reading Hospital and Medical Center Clinical Trials Office

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

View More »

Pittsburgh : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Texas

Houston : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Utah

Salt Lake City : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Canada

Halifax : Call For Information

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)